Our Work

Drivers Analysis is a sophisticated statistical technique that delivers penetrating, next-level insights by disentangling the underlying causes of specific outcomes – so you learn not only ’what’ but ‘why’.

Our survey of 190 U.S. endocrinologists finds GLP-1 and SGLT2 prescribing at 90%+ and rising, while many patients resist starting basal insulin.

This study explores how activity monitoring mobile apps and software impact overall health outcomes in PWT2, focusing on both physical and mental well-being.